North America Epinephrine Market
No. of Pages: 126 | Report Code: TIPRE00009746 | Category: Life Sciences
No. of Pages: 126 | Report Code: TIPRE00009746 | Category: Life Sciences
The growth of the market is driven by factors such as the fast growth of auto-injector production in North America and the growing prevalence of anaphylaxis cases in the North American region. Whereas, lack of availability of epinephrine drug is likely to have a negative impact on the growth of the market in the coming years.
Anaphylaxis is a severe, life‑threatening allergic reaction characterized by symptoms such as skin redness and itching, swallowing and breathing difficulties, wheezing, rapid breathing rate (tachypnoea), accelerated heart rate (tachycardia), and falling blood pressure. It may involve multiple systems of human body. Anaphylaxis is caused by exposure to an allergen (foods, insect stings, or medicines) that is recognized as a non-self by a human body.
The incidence of anaphylaxis is increasing, as per Allergy Facts by the American College of Allergy, Asthma & Immunology, and more than 50 million Americans experience different types of allergies every year. Moreover, it also lists allergies as the sixth-leading cause of chronic illness in the US and the most common health issues in children. In 2015, 8.2% of adults and 8.4% of children were diagnosed with hay fever. According to the Asthma and Allergy Foundation of America, in the last few years, hospital visits have also increased due to food allergic reaction. According to Food Allergy Research & Education, ~32 million Americans are living with life-threatening food allergies, and there are 200,000 visits to the emergency room every year due to food allergies. Allergies put an economic burden on healthcare systems in many countries; for example, according to Allergy Facts, the annual cost of managing the cases of allergies is more than USD 18 billion in the US. Anaphylaxis requires immediate medical treatment, and it can turn lethal if not treated properly. ~90–100 Americans die every year due to anaphylaxis caused by insect stings.
Therefore, the demand for epinephrine is expected to increase during the forecast period.
The rising number of the anaphylaxis cases in North America is expected to drive epinephrine market growth as Americans are more prone to allergy and infections. As in other North American countries, US faces a continuous and significant increase in the number of anaphylaxis cases. This rising number of the anaphylaxis cases and the growing pharmaceutical industry in the country create a lucrative opportunity and the presence of an established market for epinephrine.
Strategic insights for the North America Epinephrine provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 841.86 Million |
| Market Size by 2027 | US$ 1,598.99 Million |
| Global CAGR (2019 - 2027) | 8.5% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
The geographic scope of the North America Epinephrine refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.
The List of Companies - North America Epinephrine Market
The North America Epinephrine Market is valued at US$ 841.86 Million in 2019, it is projected to reach US$ 1,598.99 Million by 2027.
As per our report North America Epinephrine Market, the market size is valued at US$ 841.86 Million in 2019, projecting it to reach US$ 1,598.99 Million by 2027. This translates to a CAGR of approximately 8.5% during the forecast period.
The North America Epinephrine Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Epinephrine Market report:
The North America Epinephrine Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Epinephrine Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Epinephrine Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
UK+442030260021, US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For North America Epinephrine Market
